As we do each year when we sit down to write this article, we begin by first taking a look back at last year’s M&A Review. We concluded with a prediction and a promise. First, we anticipated some re-emergence of larger deals, then we promised to discuss athenahealth’s (#22) $293 million acquisition of mobile physician tools vendor, Epocrates.
As we do each year when we sit down to write this article, we begin by first taking a look back at last year’s M&A Review. We concluded with a prediction and a promise. First, we anticipated some re-emergence of larger deals, then we promised to discuss athenahealth’s (#22) $293 million acquisition of mobile physician tools vendor, Epocrates. Candidly, I’d give our prediction a B at best.
